To investigate whether squamocin could inhibit tumor growth by targeting the EZH2‐MYC axis in vivo, we generated a nude mouse xenograft model of HNSCC with stable EZH2 overexpression. This evidence concerns the gene MYC and head and neck squamous cell carcinoma.